What type of study is this?

This is a Meta-Analysis study (also classified as: Systematic Review).

The endocannabinoid system as a therapeutic target in prodromal psychosis: From molecular mechanisms to clinical applications

View Full Paper

Ask AI

Bookmark

Authors

Systematic review highlights endocannabinoid system's role in prodromal psychosis, suggesting therapeutic options may alter disease trajectory.

Cannabidiol intervention improves symptoms associated with the endocannabinoid system in prodromal psychosis, indicating potential therapeutic benefits.
Neuroimaging studies reveal altered receptor availability correlating with symptom severity in individuals at high risk for psychosis.
Analysis of various studies examines potential ECS alterations that contribute to early psychotic symptoms, providing insights for future interventions.
Emerging evidence suggests that targeting the endocannabinoid system may offer novel mechanisms for treating individuals at clinical high risk.

Ricci et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Systematic review highlights endocannabinoid system's role in prodromal psychosis, suggesting therapeutic options may alter disease trajectory.